Treatment-related chronic myelogenous leukemia

Annals of Hematology

Volumn 78, Issue 8, 1999, Pages 341-354

  Waller, C F ^a   Fetscher, S ^a   Lange, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chemotherapy; CML; Immunosuppression; Radiotherapy; Secondary leukemia

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; OKT 3; PLATINUM DERIVATIVE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; THIOTEPA;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANKYLOSING SPONDYLITIS; ATOMIC BOMB SURVIVOR; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; HYPERTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCHOOL CHILD; UTERUS BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; RADIOTHERAPY;

EID: 0032849424     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050527     Document Type: Review

References (126)

1. Adler KR, Lempert N, Scharfman WB (1978) Chronic granulocytic leukemia following successful renal transplantation. Cancer 41:2206-2208
2. 131I treatment of thyroid cancer. Comments on the article "Second cancer following chemotherapy and radiotherapy - an epidemiological perspective" by J. Kaldor. Acta Oncol 31:65
3. Aguiar RCT (1998) Therapy-related chronic myelogenous leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 29:17-26
4. Aguiar RC, Sill H, Hochhaus A, Cross NC (1996) Molecular investigation of secondary myeloid leukemia. Blood 88:2808-2809
5. Alfiar F, Amato D, Lipton J (1997) Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine. Leuk Lymphoma 27:365-367
6. Antin JH, Shulmann LN (1993) Therapy-related second malignancies. Hematol Oncol Clin North Am 7:325-336
7. Au WY, Klasa RJ, Gallagher R, Le N, Gascoyne RD, Connors JM (1998) Second malignancies in patients with hairy cell leukemia in British Columbia: a 20-year experience. Blood 92:1160-1164
8. Auerbach HE, Stelmach T, LaGuette JG, Glick JH, Kant JA, Nowell PC (1987) Secondary Ph-positive CML with a minority monosomy 7 clone. Cancer Genet Cytogenet 28:173-178
9. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Fessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkarnp N, Stephenson JR, Groffen J (1983) Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 306:277-280
10. Battin J, Hehunstre JP, Bui NB, Auzerie J, Colle M (1976) Chronic myeloid leukemia after immunosuppressive treatment for chronic nephropathy (letter). Nouv Presse Med 5:2632
11. Beaty O III, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, Thompson El, Pratt CB (1995) Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609
12. Berman E, Strife A, Wisniewski D, Desai S, Gulati S, Jhanwar S, Clarkson B (1991) Duration of the preclinical phase of chronic myelogenous leukemia: a case report. Blood 78:2969-2972
13. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751
14. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118-3122
15. Blayney DW, Longo DL, Young RC, Greene MH, Hubbard SM, Postal MG, Duffey PL, DeVita VT (1987) Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316:710-714
16. Boice JD (1981) Cancer following medical irradiation. Cancer 47:1081-1090
17. Boice JD, Inskip PD. (1996) Radiation-induced leukemia. In:, Henderson ES, Lister TA, Greaves MF (eds) Leukemia. Saunders, Philadelphia, pp 195-209
18. Boice JD, Day N, Andersen A, Brinton L, Brown L, Choi N, Clarke E, Coleman M, Curtis R, Flannery J, Hakama M, Hakulinen T, Howe G, Jensen O, Kleinerman R, Magnin D, Magnus K, Makela K, Malker B, Miller A, Nelson N, Patterson C, Petterson F, Pompe-Kim V, Primic-Zakelj M, Prior P, Ravnihar B, Skeet R, Skjerven J, Smith P, Sok M, Spengler R, Storm H, Stovall M, Tomkins G, Wall C (1985) Second cancers following radiation treatment of cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 74:955-975
19. Boice JD, Blettner M, Kleinerman RA, Stovall M, Moloney WC, Engholm G, Austin D, Bosch A, Cookfair D, Krementz E, Latourette H, Peters L, Schulz M, Lundell M, Petterson F, Storm H, Bell C, Coleman M, Fraser P, Palmer M, Prior P, Choi N, Hislop T, Koch M, Robb D, Robson D, Spengler R, von Fournier D, Frischkorn R, Lochmüller H, Pompe-Kirn V, Rimpela A, Kjorstad K, Pejovic M, Sigurdsson K. Pisani P, Kucera H, Hutchinson G (1987) Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst 79:1295-1311
20. Bokemeyer C, Schmoll HJ (1995) Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 13:283-292
21. Bouabdallah K, Marit G, Reiffers J, Braustet A, Bilhou-Nabera C, Wen Z, Bernard P (1991) Hodgkin's disease and secondary Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer Genet Cytogenet 55:277-278
22. 131I treatment of thyroid carcinoma. Br J Cancer 28:232-237
23. Browett PJ, Pattinson J, Pinkney J, Hoffbrand AV, Norton JD (1988) Gene probe analysis demonstrates independent clonal evolution of co-existent chronic myeloid and chronic lymphocytic leukaemia. Eur J Haematol 40:181-184
24. Brownlie B (1967) Leukaemia following radioiodine treatment of thyrotoxicosis. N Z Med J 67:621-622
25. Bundi R, Scott J, Halnan K (1977) Chronic myeloid leukaemia following radioiodine therapy for carcinoma of the thyroid. Br J Radiol 50:61-64
26. Canellos GP, Whang-Peng J (1972) Philadelphia-chromosome-positive preleukemic state. Lancet 1:1227-1228
27. Carcassone Y, Gascard E (1968) Leucémie myéloide succédant à une leucémie lymphoide. Marseille Méd 105:339-341
28. Catovsky D (1979) Phi-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases? Br J Haematol 42:493-498
29. Cazzola M, Bergamaschi G, Melazzini M, Ponchio L, Rosti V, Molinari E (1990) Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin's lymphoma. Haematologica 75:477-479
30. Chap L, Nimer S (1994) Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X. Leuk Lymphoma 12:315-316
31. Coltman CA, Dixon DO (1982) Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year follow-up. Cancer Treat Rep 66:1023-1033
32. Court Brown W, Doll R (1957) Leukaemia and aplastic anaemia in patients irradiated for ankylosing spondylitis. British Medical Research Council, London
33. Curtis RE, Boice JD jr, Stovall M, Flannery JT, Moloney WC (1989) Leukemia risk following radiotherapy for breast cancer. J Clin Oncol 7:21-29
34. Curtis RE, Boice JD jr, Moloney WC, Ries LG, Flannery JT (1990) Leukemia following chemotherapy for breast cancer. Cancer Res 50:2741-2746
35. Curtis R, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN (1992) Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745-1751
36. Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824-830
37. Dutrillaux B, Viegas-Pequignot E, Prod'homme M, Sportes M (1985) Distribution of the various radiation-induced chromosomal rearrangements in relation to the dose and sampling time. Mutat Res 152:197-203
38. Ezdinli E, Sokol J, Aungst G, Kior V, Sandberg A (1969) Myeloid leukemia in Hodgkin's disease: chromosomal abnormlities. Ann Intern Med 71:1097-1100
39. Frist W, Biggs V (1994) Chronic myelogenous leukemia after lymphoid irradiation and heart transplantation. Ann Thorac Surg 57:214
40. Glicksman AS, Pajak TF, Gottlieb A, Nis N, Stutzman L, Cooper MR (1982) Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. Cancer Treat Rep 66:1035-1044
41. Graciansky P, Paraf A (1950) Les correlations medullo-sanguines dans les hematodermies et, en particulier, dans les granulomatoses. Semin Hop Paris 26:2112-2121
42. Grünwald H, Rosner F (1996) Chemicals and leukemia. In: Henderson ES, Lister TA, Greaves MF (eds) Leukemia. Saunders, Philadelphia, pp 179-194
43. Haas JF, Kittelmann B, Mehnert WH, Staneczek W, Mohner M, Kaldor JM, Day NE (1987) Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 55:213-218
44. Haq AU (1990) Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol 35:110-113
45. Hasegawa A, Ninomiya H, Yanagisawa K, Takada K, Hasegawa H, Hato T, Yasukawa M, Fujita S (1996) Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma. Rinsho Ketsuecki 37:853
46. Hashimi L, Al-Katib A, Mertelsmann R, Mohamed AN, Koziner B (1986) Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia. Am J Med 80:269-275
47. Hawkins M, Kinnier Wilson L, Stovall M, Marsden H, Potok M, Kingston J, Chessels J (1992) Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 304:951-958
48. Hilario R, Padre-Mendoza T, Albala MM (1980) Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation. Am J Med Sci 280:115-118
49. Holmberg M (1992) Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation? Leuk Res 16:333-336
50. Hoppin EC, Lewis JP (1975) Polycythemia rubra vera progressing to Phi-positive chronic myelogenous leukemia. Ann Intern Med 83:820-823
51. Inskip PD, Monson RR, Wagoner JK, Stovall M, Davis FG, Kleinerman RA, Boice JD jr (1990) Leukemia following radiotherapy for uterine bleeding. Radiat Res 122:107-119
52. Iurlo A, Foa P, Maiolo AT, Polli EE (1989) Chronic myelogenous leukemia following radiation therapy for testicular seminoma. Blut 59:503-504
53. Jackson GH, Latham JA, Lennard AL, Taylor PR, Proctor SJ (1994) Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease. Br J Haematol 87:193-195
54. Jacobs RH, Vokes EE, Golomb HM (1985) Second malignancies in hairy cell leukemia. Cancer 56:1462-1467
55. Jensen MK (1970) Effect of azathioprine on the chromosome complement of human bone marrow cells. Int J Cancer 5:147-151
56. Johnson FD, Jacobs EM, Wood DA (1966) Hodgkin's disease terminating in chronic myeloid leukemia. Calif Med 104:479-484
57. Jones CT (1971) A case of chronic myeloid leukaemia in a patient previously treated with radiotherapy for localized reticulum cell sarcoma. Br J Radiol 44:801-802
58. Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D, Koch M, Choi W, Prior P, Blair V, Langmark F, Pompe Kirn V, Neal F, Peters D, Pfeiffer R, Karjalainen S, Cuzick J, Sutcliffe SB, Somers R, Pellae-Cosset B, Pappagallo GL, Fraser P, Storm H, Stovall M (1990) Leukemia following Hodgkin's disease. N Engl J Med 322:7-13
59. Kaldor JM, Day NE, Pettersson F, Clarke EA, Pedersen D, Mehnert W, Bell J, Host H, Prior P, Karjalainen S, Neal F, Koch M, Band P, Choi W, Pompe Kirn V, Arslan A, Zaren B, Belch AR, Storm H, Kittelmann B, Fraser P, Stovall M (1990) Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1-6
60. Kamada N, Uchino H (1978) Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. Blood 51:843-850
61. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M (1993) Chronic myelogenous leukemia: a concise update. Blood 82:691-703
62. Karp JE, Smith MA (1997) The molecular pathogenesis of treatment-induced (secondary) leukemias: foundation for treatment and prevention. Semin Oncol 24:103-113
63. Khojasteh A, Perry MC, Taylor HM (1981) Chronic myelocytic leukemia developing as a second cancer in a patient with chronic lymphocytic leukemia. CA Cancer J Clin 31:172-176
64. Kirchner KA, Files JC, Didlake R, Raju S, Krueger RP (1983) Chronic granulocytic leukemia after renal transplantation. Arch Intern Med 143:1984-1987
65. Koeffler HP, Golde DW (1991) Chronic myelogenous leukemia: new concepts. N Engl J Med 304:1201-1209
66. Koulischer L, Fruhing J, Henry J (1967) Cytogenetic findings in Vaquez' disease. Eur J Cancer 3:193-201
67. Larson RA, Le Beau MM, Ratain MJ, Rowley JD (1992) Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. Blood 79:1892-1893
68. 198Au synoviorthesis. J Rheumatol 18:734-735
69. Lubynski R, Meyers A, Disler P, MacPhail A, Myburgh J, Katz J (1978) Chronic granulocytic leukemia in a patient with a renal allograft. Arch Intern Med 138:1429-1430
70. Majado M, Gonzalez Garcia C, Marin-Blazquez M, Morales Lazaro A, Moreno Moreno M (1992) Emergence of chronic myeloid leukemia in Waldenström macroglobulinemia. Sangre 37:465-466
71. Meadows AT, Jarrett P (1978) Pigmented nevi, Wilms' tumor, and second malignant neoplasms. J Pediatr 93:889-890
72. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin R, Marsden B, Neshit M, Newton W, Oberlin O, Sallan SG, Siegel S, Strong LC, Voute P (1985) Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 3:532-538
73. Michalski KA, Miles JH, Perry MC (1982) Unusual Ph translocation in a preleukemia. Cancer Genet Cytogenet 6:89-90
74. Modan B, Lilienfeld AM (1965) Polycythemia rubra vera and leukemia - the role of radiation treatment. A study of 1222 patients. Medicine 44:305
75. Moloney WC (1987) Radiogenic leukemia revisited. Blood 70:905-908
76. Mooy JM, Hagenouw-Taal JC, Lameijer LD, van Tumhout JM (1978) Chronic granulocytic leukemia in a renal transplant recipient. Cancer 41:7-9
77. Moss TJ, Strauss LC, Das L, Feig SA (1989) Secondary leukemia following successful treatment of Wilms' tumor. Am J Ped Hematol Oncol 11:158-161
78. Nandakumar A, Davis S, Moolgavkar S, Witherspoon RP, Schwartz SM (1991) Myeloid leukaemia following therapy for a first primary cancer. Br J Cancer 63:782-788
79. Nanjangud GJ, Saikia TK, Chopra H, Kadam PR, Advani SH (1996) Development of Ph-positive chronic myeloid leukemia in a patient with chronic lymphocytic leukemia treated with total body irradiation: a rare association. Leuk Lymphoma 22:355-359
80. Nowell PC, Jackson L, Weiss A, Kurzrock R (1988) Historical communication: Philadelphia-positive chronic myelogenous leukemia followed for 27 years. Cancer Genet Cytogenet 34:57-61
81. Offit K, Burns JP, Cunningham I, Jhanwar SC, Black P, Kernan NA, O'Reilly RJ, Chaganti RS (1990) Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood 75:1346-1355
82. 131 therapy for metastatic thyroid carcinoma. Am J Roentgenol Rad Ther Nucl Med 85:914-918
83. Pedersen-Bjergaard J, Rowley JD (1994) The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786
84. Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, Rorth M (1991) Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 338:359-363
85. Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, Osterlind K (1993) Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7:1975-1986
86. Pedersen-Bjergaard J, Brondum-Nielsen K, Karle H, Johansson B (1997) Chemotherapy-related - and late-occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors. Leukemia 11:1571-1574
87. Pedersen-Bjergaard J, Andersen MK, Johansson B (1998) Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Clin Oncol 16:1897-1898
88. Penn I (1988) Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev 12:39-57
89. Penn I (1994) Commentary to Frist W, Biggs V: Chronic myelogenous leukemia after lymphoid irradiation and heart transplantation. Ann Thorac Surg 57:214
90. Philip P, Pedersen-Bjergaard J (1988) Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias. Cancer Genet Cytogenet 31:227-236
91. Propp S, Lizzi FA (1970) Philadelphia chromosome in acute lymphocytic leukemia. Blood 36:353-360
92. Punt CJ, Rozenberg-Arska M, Verdonck LF (1987) Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis for chronic myelogenous leukemia following advanced Hodgkin's disease. Cancer 60:934-935
93. Reeves JE, Robbins BA, Pankey LR, Elias AL, Anderson WF (1995) The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report. Cancer 75:2089-2092
94. Ritch PS, Anderson T, Hanson GA, Pisciotta AV (1983) Chronic granulocytic leukemia following radiation therapy for Hodgkin's disease. Cancer 52:462-464
95. Robinson B, Colls B, Fitzharris B, Atkinson C (1994) Second malignant neoplasms in patients with Hodgkin's disease. Aust N Z J Med 24:368-373
96. Rosner F, Carey RW, Zarrabi MH (1978) Breast cancer and acute leukemia: report of 24 cases and review of the literature. Am J Hematol 4:151-172
97. Roth AD, Oral A, Przepiorka D, Gollin SM, Chervenick PA (1993) Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera. Am J Hematol 43:123-128
98. Roth MS, Antin JH, Bingham EL, Ginsburg D (1989) Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 74:882-885
99. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61:1132-1137
100. Saenger EL, Thoma GE, Tompkins EA (1968) Incidence of leukemia following treatment of hyperthyroidism. JAMA 205:855-862
101. Salvagno L, Soraru M, Leszl A, Koussis H, DeFranchis G, Fiorentino M (1994) Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for Hodgkin's disease. Leuk Lymphoma 16:177-181
102. Sanz L, Cervantes F, Esteve J, Vilardell J, Marin P, Rozman C, Montserrat E (1996) Chronic myeloid leukemia after renal transplantation: a report of a case and review of the literature. Sangre 41:391-395
103. Schreiber ZA, Axelrod MR, Abebe LS (1984) Coexistence of chronic myfelogenous leukemia and chronic lymphocytic leukemia. Cancer 54:697-701
104. Schwartz AD, Lee H, Baum ES (1975) Leukemia in children with Wilms' tumor. J Pediatr 87:374-376
105. 131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol 43:651-654
106. Stein AM, Anthone R, Anthone S, Marinello MJ, Elwood CM, Bannerman RM (1978) Chronic myelocytic leukemia in a young renal allografted patient. Transplantation 26:271-273
107. Stuppia L, Calabrese G, Peila R, Guanciali-Franchi P, Morizio E, Spadano A, Palka G (1997) p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis. Cancer Genet Cytogenet 98:28-35
108. Swaim WR, Windschitl HE, Doscherholmen A, Bankole RO, Bates HA (1971) Chronic myelogenous leukemia in Hodgkin's disease: immunofluorescence of cells. Cancer 27:569-573
109. Swerdlow AJ, Douglas AJ, Hudson GV, Hudson BV, Bennett MH, MacLennan KA (1992) Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143
110. Teichmann JV, Sieber G, Ludwig WD, Karow J, Ruehl H (1986) Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia. Case report and review of the literature. Leuk Res 10:361-368
111. Tester WJ, Kinsella TJ, Waller B, Makuch RW, Kelley PA, Glatstein E, DeVita VT (1984) Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol 2:762-769
112. Travis LB, Curtis RE, Boice JD jr, Hankey BF, Fraumeni JF jr (1991) Second cancers following non-Hodgkin's lymphoma. Cancer 67:2002-2009
113. Travis LB, Curtis RE, Hankey BF, Fraumeni JF jr (1992) Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 84:1422-1427
114. Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P (1993) Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932-1937
115. Travis LB, Curtis RE, Hankey BF, Fraumeni JF jr (1993) Acute non-lymphocytic leukemia after small-cell lung cancer. J Clin Oncol 11:586-587
116. Travis LB, Curtis RE, Boice JD, Platz CE, Hankey BF, Fraumeni JF jr (1996) Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 56:1564-1570
117. Tucker M, Coleman C, Cox R, Varghese A, Rosenberg S (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81
118. Verhoef G, Demuynck H, Stul M, Cassiman J, Mecucci C, Van den Berghe H, Boogaerts M (1990) Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet Cytogenet 49:171-176
119. 131I for thyroid carcinoma. Cancer Genet Cytogenet 55:217-224
120. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181-186
121. Waller CF, Fetscher S, Lange W (1999) Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer. Leuk Res (in press)
122. Wanders J, Wattendorff A, Endtz L, den Nijs J, Leeksma C (1981) Chronic myeloid leukemia in myasthenia gravis after long-term treatment with 6-mercaptopurine. Acta Med Scand 210:235-238
123. Weinberg JB (1989) Sequential development of polycythemia vera and chronic myelocytic leukemia in a patient following radiation exposure from nuclear weapons tests. Am J Med 87:121-123
124. Whang-Peng J, Gralnick HR, Johnson RE, Lee EC, Lear A (1974) Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics. Blood 43:333-339
125. Whang-Peng J, Young R, Lee E, Longo D, Schechter G, DeVita V (1988) Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 71:403-414
126. Wolden SL, Lambom KR, Cleary SF, Tate DJ, Donaldson SS (1998) Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16:536-544